B cells are essential for moderating the inflammatory response and controlling bacterial multiplication in a mouse model of vaccination against Chlamydophila abortus infection.
The use of inactivated vaccines associated with suitable adjuvants has been demonstrated to confer a good level of protection against Chlamydophila abortus. However, the basis of the immune protective response induced by these vaccines has been poorly studied. B cells act as an immune regulatory population during primary infection by C. abortus. Thus, it was considered of interest to study the role of B cells in an infection after immunization with a killed vaccine. For this, C57BL/6 and B-cell-deficient mice were immunized with a killed vaccine against C. abortus using QS-21 as the adjuvant. After challenge, the course of infection was established by analysis of morbidity, C. abortus burden in the liver, and histopathological changes. The immune response induced was studied by real-time PCR techniques. Experiments involving transfer of immune serum from vaccinated or previously infected mice were also carried out. The lack of B cells reduced the protection conferred by the QS-21 adjuvant vaccine. Vaccinated B-cell-deficient mice showed a 1,000-fold-greater bacterial burden in the liver than their wild-type counterparts. Obvious differences existed in the liver, where a severe neutrophilic reaction and extended areas of necrosis were observed with vaccinated B-cell-deficient mice. An analysis of the immune response pointed to a significant increase in inflammatory cytokines and chemokines and the deficient production of transforming growth factor beta. The transfer of antibodies restored the level of protection. This study demonstrates that B cells play a crucial role in controlling C. abortus multiplication and prevent an exacerbated inflammatory response.
Buendía
Antonio J
AJ
Departamento de Anatomía y Anatomía Patológica Comparadas, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo, 30100 Murcia, Spain. abuendia@um.es
Ortega
Nieves
N
Caro
María R
MR
Del Río
Laura
L
Gallego
María C
MC
Sánchez
Joaquín
J
Navarro
Jose A
JA
Cuello
Francisco
F
Salinas
Jesús
J
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D058491:Bacterial Load / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology / Q000494:pharmacology*; D023521:Chlamydophila Infections / Q000276:immunology* / Q000382:microbiology / Q000473:pathology*; D016207:Cytokines / Q000096:biosynthesis; D004195:Disease Models, Animal; D005260:Female; D007249:Inflammation / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012503:Saponins / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D016207:Cytokines; D012503:Saponins; C078785:saponin QA-21V1
Adv Immunol. 2006;91:1-44
16938537
Res Microbiol. 1994 Oct;145(8):611-20
7871240
Infect Immun. 2005 Feb;73(2):1141-50
15664957
Infect Immun. 1983 Nov;42(2):525-30
6642642
FEMS Microbiol Lett. 1997 May 1;150(1):113-9
9163915
Infect Immun. 1995 Dec;63(12):4912-6
7591155
J Virol. 2003 Feb;77(4):2578-86
12551996
J Immunol. 2005 Dec 1;175(11):7536-42
16301662
J Immunol. 2007 Jun 1;178(11):7222-34
17513771
Infect Immun. 1997 Jun;65(6):1993-9
9169723
Infect Immun. 2008 Oct;76(10):4642-8
18663004
J Comp Pathol. 2003 May;128(4):217-44
12834606
Infect Immun. 2000 Mar;68(3):1746-51
10679002
J Immunol. 2003 Jun 15;170(12):5897-911
12794116
Expert Rev Vaccines. 2004 Feb;3(1):23-34
14761241
J Immunol. 2004 Nov 15;173(10):6346-56
15528374
Cardiovasc Res. 2005 Feb 1;65(2):317-27
15639470
Vet J. 2006 Mar;171(2):263-75
16490708
Eur J Immunol. 2009 Mar;39(3):676-86
19283721
Vaccine. 2003 Jul 4;21(23):3126-36
12804839
Infect Immun. 2001 Aug;69(8):4808-15
11447154
Infect Immun. 2002 Jun;70(6):2741-51
12010958
Infect Immun. 2007 Oct;75(10):4933-41
17664264
Infect Immun. 2008 Dec;76(12):5581-7
18809664
J Biomol Tech. 2003 Mar;14(1):33-43
12901609
J Exp Med. 1998 Feb 16;187(4):619-29
9463412
Immunol Rev. 2008 Aug;224:201-14
18759928
Infect Immun. 2004 Nov;72(11):6191-6
15501743
Infect Immun. 2001 Jan;69(1):194-203
11119506
Infect Immun. 2003 Dec;71(12):7219-22
14638821
Vaccine. 1990 Aug;8(4):342-6
2396474
Vet Microbiol. 2009 Mar 16;135(1-2):103-11
18945558
Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):76-86
17092568
Nat Rev Immunol. 2005 Feb;5(2):149-61
15688042
J Immunol. 1999 Feb 15;162(4):2217-26
9973497
J Immunol. 2008 Mar 1;180(5):3329-38
18292558
Infect Immun. 2002 Dec;70(12):6911-8
12438369
Immunology. 1994 Apr;81(4):631-6
8039814
J Immunol. 2000 Mar 1;164(5):2629-34
10679102
J Immunol. 2006 Jan 15;176(2):705-10
16393950
Infect Immun. 1998 May;66(5):2128-34
9573099
Immunology. 1992 Oct;77(2):284-8
1427980
Immunology. 2002 Feb;105(2):213-21
11872097
Infect Immun. 1999 May;67(5):2110-6
10225862
Infect Immun. 2002 Feb;70(2):844-50
11796619
Microb Pathog. 2002 Jul;33(1):7-15
12127795
J Immunol. 2000 Apr 1;164(7):3681-8
10725726
Infect Immun. 1997 Jul;65(7):2876-82
9199462